6 Best-Performing Marijuana ETFs for December 2024
Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on our website or click to take an action on their website. However, this does not influence our evaluations. Our opinions are our own. Here is a list of our partners and here's how we make money.
The investing information provided on this page is for educational purposes only. NerdWallet, Inc. does not offer advisory or brokerage services, nor does it recommend or advise investors to buy or sell particular stocks, securities or other investments.
The best-performing marijuana ETF by one-year performance is AdvisorShares Vice ETF (VICE).
Investing in cannabis — including cannabis ETFs — comes with considerable risk.
Individual stocks get all the attention, but marijuana exchange-traded funds may be a better alternative. Marijuana ETFs let you invest in companies that operate in every vertical of the marijuana industry, from product conception to consumption.
For example, the AdvisorShares Pure US Cannabis ETF (by far the largest cannabis ETF in terms of assets under management) invests in companies from across the entire marijuana industry, including:
GW Pharmaceuticals (cannabinoid-focused medicine).
Cronos Group (production and distribution).
Canopy Growth Corporation (research and product development).
Aurora Cannabis (product development and production).
Investing in marijuana ETFs spreads your risk across multiple companies and segments of the industry, rather than concentrating it in any single stock. This strategy, known as diversification, is a proven method in any kind of investing, but it’s especially important in a sector as new and volatile as the cannabis industry.
» MORE: See the overall best-performing ETFs
Best-performing marijuana ETFs
Below are the best-performing cannabis ETFs available to U.S. investors (excluding the over-the-counter market). It’s important to remember that past performance doesn’t guarantee future results, but looking at a fund’s recent price movements often provides a good place to start your search.
For a deeper dive, look into the fund's three-year or five-year returns (if it's old enough to have them) to see how the fund has performed over longer periods.
Ticker | Company | Performance (Year) |
|---|---|---|
VICE | AdvisorShares Vice ETF | 27.84% |
TOKE | Cambria Cannabis ETF | -0.54% |
YOLO | AdvisorShares Pure Cannabis ETF | -7.22% |
MJ | Amplify Alternative Harvest ETF | -16.83% |
CNBS | Amplify Seymour Cannabis ETF | -20.63% |
MSOS | AdvisorShares Pure US Cannabis ETF | -33.19% |
Source: Finviz. Data is current as of market close Nov. 29 2024, and is intended for informational purposes only, not for trading purposes.
Marijuana ETFs vs. stocks
There are hundreds of cannabis stocks to choose from, many of them risky penny stocks or stocks of companies with extremely small market capitalizations. Given the industry’s young age, there’s ample room for shakeouts that could significantly affect a stock’s price. There will likely be many losers, and it’s hard to predict the number of potential winners. The current state of the industry makes an already risky strategy — picking individual stocks — even riskier.
Marijuana ETFs still come with considerable risk, but you’ll at least broaden your exposure to dozens of companies. If one company in the fund fails, ideally those losses will be offset by another company’s success. It’s true that you could miss out on the sky-high returns of an individual breakout stock, but investing in ETFs could help you avoid the significant losses investors are likely to see in such an unproven industry.
» Need a brokerage account? Here are our top brokerage options for buying an ETF
The risks of marijuana ETFs
Investing in cannabis — including cannabis ETFs — comes with considerable risk. Regulatory uncertainty, financing hurdles and sheer unpredictability in business models and operations could significantly and quickly alter the future landscape and, in turn, the value of marijuana stocks and ETFs.
Regulation
While recreational marijuana consumption and possession is now legal in several states (and medical marijuana is legal in even more), in the eyes of the federal government, it’s still an illegal substance. The recent proposition to shift it from Schedule I to Schedule III could open up more avenues for medical research and commercialization, but it stops short of full recreational legalization.
This classification could also lead to gray areas between state and federal laws. For example, the U.S. attorney general has the power to decide whether the Justice Department will enforce federal marijuana laws within states that have passed legalization laws, and this stance has already shifted from one presidential administration to the next. As long as enforcement is fluid, uncertainty will persist.
Financing and banking
While the earliest dispensaries and marijuana businesses may have struggled to find traditional financing and banking services, that isn’t as big of a concern today, and more change could be on the horizon.
In 2023, the Secure and Fair Enforcement Banking Act was reintroduced in the House. If it becomes law, it would help protect depository institutions that supply financial services to marijuana companies. Moreover, the National Credit Union Administration issued interim guidance in 2019 to help credit unions navigate how to provide services to legal hemp businesses. This guidance was in response to the 2018 Farm Bill, which delisted hemp (which, in this context, means a marijuana plant containing less than 0.3% of the psychoactive ingredient THC) as a controlled substance at the federal level.
On top of all that, the number of depository institutions that provide banking services to marijuana companies has risen steadily since 2014, reaching 553 banks and 162 credit unions by the third quarter of 2019, up from about 100 banks and a handful of credit unions five years earlier.
Still, many of these developments aren't yet concrete. While they suggest legislation favorable to the marijuana industry could be forthcoming, the landscape is still being formed, which will likely result in continued uncertainty in the short term.
Volatility
If you’re a new investor or are looking for predictability, there are other index funds and ETFs better suited for you. But if you’re willing to stomach the volatility of an uncertain market in exchange for getting in at an extremely early stage — and your portfolio is in a well-diversified, healthy state — you may have a case for investing in cannabis ETFs.
Learn more about sector ETFs:
